Bradley Foster & Sargent Inc Becton Dickinson & CO Transaction History

Bradley Foster & Sargent Inc

$5.77 Billion
Q4 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 21,721 shares of BDX stock, worth $4.99 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

21,721

Previous 26,452 17.89%

Holding current value

$4.99 Million

Previous $6.38 Million 22.74%

% of portfolio

0.09%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$220.02 - $243.75 $1.04 Million - $1.15 Million	-4,731 Reduced 17.89%	21,721 $4.93 Million
Q3 2024 Nov 04, 2024	SELL	$221.47 - $242.41 $4 Million - $4.38 Million	-18,063 Reduced 40.58%	26,452 $6.38 Million
Q2 2024 Aug 09, 2024	SELL	$225.07 - $246.17 $197,386 - $215,891	-877 Reduced 1.93%	44,515 $10.4 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $215,240 - $228,407	-922 Reduced 1.99%	45,392 $11.2 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $186,953 - $215,120	-805 Reduced 1.71%	46,314 $11.3 Million
Q2 2023 Aug 08, 2023	BUY	$238.39 - $265.32 $5.64 Million - $6.27 Million	23,648 Added 100.75%	47,119 $12.4 Million
Q1 2023 May 08, 2023	SELL	$229.71 - $259.35 $24,349 - $27,491	-106 Reduced 0.45%	23,471 $5.81 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $22,920 - $26,975	105 Added 0.45%	23,577 $6 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $67,767 - $350,897	-1,328 Reduced 5.35%	23,472 $5.23 Million
Q2 2022 Aug 11, 2022	BUY	$234.74 - $275.42 $35,915 - $42,139	153 Added 0.62%	24,800 $6.11 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $648,082 - $719,476	2,660 Added 12.1%	24,647 $6.56 Million
Q4 2021 Mar 11, 2022	SELL	$230.08 - $250.94 $3.2 Million - $3.49 Million	-13,894 Reduced 38.72%	21,987 $5.53 Million
Q3 2021 Nov 10, 2021	SELL	$232.72 - $256.47 $1.72 Million - $1.9 Million	-7,390 Reduced 17.08%	35,881 $8.82 Million
Q2 2021 Aug 19, 2021	SELL	$232.65 - $254.58 $289,416 - $316,697	-1,244 Reduced 2.79%	43,271 $10.5 Million
Q1 2021 Apr 26, 2021	SELL	$232.09 - $256.88 $22.4 Million - $24.8 Million	-96,395 Reduced 68.41%	44,515 $10.8 Million
Q4 2020 Feb 11, 2021	SELL	$221.92 - $245.94 $125,384 - $138,956	-565 Reduced 0.4%	140,910 $35.3 Million
Q3 2020 Oct 26, 2020	BUY	$215.77 - $276.76 $3.36 Million - $4.32 Million	15,593 Added 12.39%	141,475 $32.9 Million
Q1 2020 May 07, 2020	SELL	$195.69 - $279.01 $326,215 - $465,109	-1,667 Reduced 1.31%	125,882 $28.9 Million
Q4 2019 Jan 29, 2020	BUY	$236.45 - $266.82 $762,314 - $860,227	3,224 Added 2.59%	127,549 $34.7 Million
Q3 2019 Oct 30, 2019	SELL	$230.58 - $256.08 $461,621 - $512,672	-2,002 Reduced 1.58%	124,325 $31.4 Million
Q2 2019 Aug 08, 2019	BUY	$217.4 - $246.08 $2.2 Million - $2.49 Million	10,130 Added 8.72%	126,327 $31.8 Million
Q1 2019 May 02, 2019	BUY	$206.05 - $248.17 $888,693 - $1.07 Million	4,313 Added 3.85%	116,197 $29 Million
Q4 2018 Jan 30, 2019	BUY	$204.73 - $257.93 $17.6 Million - $22.2 Million	86,006 Added 332.35%	111,884 $25.2 Million
Q3 2018 Oct 31, 2018	BUY	$233.07 - $256.0 $413,699 - $454,400	1,775 Added 7.36%	25,878 $6.75 Million
Q2 2018 Jul 31, 2018	BUY	$208.1 - $233.85 $72,626 - $81,613	349 Added 1.47%	24,103 $5.77 Million
Q1 2018 May 07, 2018	BUY	$205.46 - $240.27 $31,846 - $37,241	155 Added 0.66%	23,754 $5.15 Million
Q4 2017 Feb 06, 2018	BUY	$189.0 - $222.64 $111,132 - $130,912	588 Added 2.56%	23,599 $5.05 Million
Q3 2017 Nov 03, 2017	BUY	$186.89 - $198.9 $4.3 Million - $4.58 Million	23,011	23,011 $4.51 Million

Others Institutions Holding BDX

# of Institutions

1,743

Shares Held

249M

Call Options Held

687K

Put Options Held

782K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.6B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Becton Dickinson & CO Transaction History